ly 311727 has been researched along with 3-(4-octadecyl)benzoylacrylic acid in 1 studies
Studies (ly 311727) | Trials (ly 311727) | Recent Studies (post-2010) (ly 311727) | Studies (3-(4-octadecyl)benzoylacrylic acid) | Trials (3-(4-octadecyl)benzoylacrylic acid) | Recent Studies (post-2010) (3-(4-octadecyl)benzoylacrylic acid) |
---|---|---|---|---|---|
33 | 1 | 6 | 7 | 0 | 5 |
Protein | Taxonomy | ly 311727 (IC50) | 3-(4-octadecyl)benzoylacrylic acid (IC50) |
---|---|---|---|
Phospholipase A2 | Homo sapiens (human) | 0.049 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Endo, S; Fujimoto, N; Fujita, M; Ikari, A; Ikeda, H; Ishikawa, T; Kamatari, YO; Kudo, Y; Matsunaga, T; Okada, T; Ota, A; Tanaka, Y; Toyooka, N | 1 |
1 other study(ies) available for ly 311727 and 3-(4-octadecyl)benzoylacrylic acid
Article | Year |
---|---|
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
Topics: Apoptosis; Autophagy; Autophagy-Related Proteins; Cell Line, Tumor; Cysteine Endopeptidases; Humans; Male; Prostatic Neoplasms, Castration-Resistant | 2022 |